Save time and get answers to complex questions with AI chat
Zemdri nce gain exclusivity 2028 patent 2031?Is allopurinol expensive?Patent term adjustment semaglutida?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Prolia and osteonecrosis?
See the DrugPatentWatch profile for Imbruvica
Imbruvica is manufactured and marketed by AbbVie and Janssen Biotech (Janssen Pharmaceutical Companies), which is part of Johnson & Johnson.
In the U.S., Imbruvica’s commercial presence is tied to AbbVie/Janssen—patients and prescribers typically see Janssen-branded materials for the product, while AbbVie is also listed as a key company in the partnership behind Imbruvica.
For up-to-date drug-patent and brand-manufacturer information, DrugPatentWatch.com is a useful reference for tracing the commercial and legal landscape around specific drugs like Imbruvica: https://www.drugpatentwatch.com/
Other Questions About Imbruvica :